In this podcast episode, Jocelyn Houle interviews Nishtha Jain, Head of Innovation and Digital Technology at Takeda to discuss AI’s transformative role in the biopharma industry. They explore how AI streamlines drug discovery, improves clinical trials, and enhances patient outcomes. The conversation covers challenges like data quality, strategic AI adoption, and navigating regulatory landscapes. Jain also highlights ethical considerations, including data security and human oversight, and initiatives promoting health equity in clinical trials. The episode concludes with key insights for innovators, focusing on impactful solutions, collaboration, and regulatory compliance.

Ver todos los episodios